Sanofi-Aventis goes hostile in Genzyme pursuit
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has launched an $18.5 billion tender offer for Genzyme, taking the bid directly to the biotech's shareholders after talks between the two firms broke down.